. home.aspx

NEWS

home.aspx
   


Phase 1 Clinical Trial for Coronavirus Vaccine Begins in Seattle

March 17, 2020 / Sara Heath
SHARESHARESHARE

Phase 1 clinical trials for a coronavirus vaccine have begun at Kaiser Permanente Washington Health Research Institute (KPWHR) has begun, according to a statement from the National Institutes of Health. The investigational vaccination, funded in part by the National Institute of Allergy and Infectious Disease, began today by administering the first immunization to a healthy adult between ages 18 and 55 years old. In total, the phase 1 clinical trial will enroll 45 adults who fit this criteria and investigate outcomes over a six-week test period.